WSJ UPDATE: Amgen Settles Antitrust Suit With Ortho Biotech - CNN Money
Amgen Inc. (AMGN) agreed to pay $200 million to settle an antitrust lawsuit by Johnson & Johnson's (JNJ) Ortho Biotech unit, putting to rest two and a half years of legal wrangling over Amgen's sales of its oncology products. Ortho, based in

Regardless of skin color, all are at risk from too much sun - St. Petersburg Times
I have to confess. For most of my life, I've been quietly amused at how my white friends have struggled with sunburn. Never in a hateful way, mind you. Outwardly, I would empathize with their plight when they arrived from the beach redder than a

Oncology Med Will Begin Servicing New Multiple Year Contract With - MSN MoneyCentral
Oncology Med, Inc. (PINKSHEETS: ONCO), a Pittsburgh-based cancer treatment solutions group, announced today that during this month of July, 2008 it will begin providing prostate cancer brachytherapy treatment services under a new multiple year

Ares Capital Corporation Arranges $100.0 Million Term Loan Facility - MSN MoneyCentral
Ares Capital Corporation ARCC is pleased to announce the closing of a $100.0 million Term Loan Facility for Vantage Oncology, Inc. ( Vantage ). Ares Capital Corporation acted as the Lead Arranger for the facility, which is structured as a

Atwood Earns Oncology Nutrition Certification - Daily News-Record
HARRISONBURG - Robin Atwood has recently achieved board certification as a specialist in oncology nutrition from the American Dietetic Association. To become board certified, a registered dietitian must successfully meet specialty practice

New Oncology Wellness Institute Committed to Whole Person Cancer Care - PR Inside
www.mmchs.org/news_new.aspx?newsId=285 - Meadville Medical Center's new Oncology Wellness Institute, an innovative state-of-the art whole person cancer center, announces its grand opening with what local doctors have described as an "unparalleled

Amgen To Pay $200 Million To J&J Unit To Settle Antitrust Suit - CNN Money
Amgen Inc. (AMGN) will pay $200 million to Ortho Biotech Products, a unit of Johnson & Johnson (JNJ), to settle an antitrust lawsuit over Amgen's marketing practices for its anemia drug Aranesp. The biotechnology giant continues to deny that its